Jean-Yves F. Pavée

PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ.

Ellerman Investments Ltd. provides financial services. The private company is based in London, UK. and has subsidiaries in United Kingdom. Ellerman Investments was founded in 1984.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

Part of Deloitte LLP (New York), Deloitte & Touche LLP UK provides financial advisory and accounting services. The company is based in Edinburgh, UK.

Part of Azure Ventures Ltd., Allergy Therapeutics (UK) Ltd. is a British company that specializes in treating various types of allergies. The company is based in Worthing, UK. The information provided in the dictionary is limited to the company's home page, history, mission, vision, and login page.

Part of SkyGem International Holdings Ltd., Allergy Therapeutics (Holdings) Ltd. is an investment holding British company. The company is based in Worthing, UK. Founded in 1998, Allergy Therapeutics (Holdings functions as an investment holding company.

Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY.

Part of Allergy Therapeutics Plc, Bencard Allergie GmbH is a German company that specializes in researching and developing drugs for the diagnosis and causal therapy of allergies. The company is based in Munich, Germany. The company's website provides concise knowledge on various allergy detection and treatment methods. Bencard Allergie was founded in 1934 and is currently led by CEOs Manuel Llobet, Bodo Steinert, and Nicolas Alexander Ulrich Wykeman.

ProAxsis Ltd. manufactures and markets pharmaceutical products . It offers clinical research and research and development services. The company was founded by Lorraine Martin and Brian Walker in August 2013 and is headquartered in Belfast, the United Kingdom.